Next Article in Journal
Investigation of Bioactive Compounds Extracted from Verbena officinalis and Their Biological Effects in the Extraction by Four Butanol/Ethanol Solvent Combinations
Previous Article in Journal
Dopamine Partial Agonists in Pregnancy and Lactation: A Systematic Review
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Pharmaceuticals
Volume 18
Issue 7
10.3390/ph18071011
pharmaceuticals-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Correction to Pharmaceuticals 2023, 16(8), 1123.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Mohammed et al. Alvespimycin Exhibits Potential Anti-TGF-β Signaling in the Setting of a Proteasome Activator in Rats with Bleomycin-Induced Pulmonary Fibrosis: A Promising Novel Approach. Pharmaceuticals 2023, 16, 1123

by
Osama A. Mohammed
1,*,
Mustafa Ahmed Abdel-Reheim
2,3,*,
Lobna A. Saleh
4,5,
Mohannad Mohammad S. Alamri
6,
Jaber Alfaifi
7,
Masoud I. E. Adam
8,
Alshaimaa A. Farrag
9,10,
AbdulElah Al Jarallah AlQahtani
11,
Waad Fuad BinAfif
12,
Abdullah A. Hashish
13,14,
Sameh Abdel-Ghany
15,
Elsayed A. Elmorsy
15,16,
Hend S. El-wakeel
17,18,
Ahmed S. Doghish
19,20,
Rabab S. Hamad
21,22 and
Sameh Saber
23,*
1
Department of Clinical Pharmacology, College of Medicine, University of Bisha, Bisha 61922, Saudi Arabia
2
Department of Pharmaceutical Sciences, College of Pharmacy, Shaqra University, Shaqra 11961, Saudi Arabia
3
Department of Pharmacology and Toxicology, Faculty of Pharmacy, Beni-Suef University, Beni Suef 62521, Egypt
4
Department of Clinical Pharmacology, Faculty of Medicine, Ain Shams University, Cairo 11566, Egypt
5
Department of Pharmacology and Toxicology, College of Pharmacy, Taif University, Taif 21944, Saudi Arabia
6
Department of Family Medicine, College of Medicine, University of Bisha, Bisha 61922, Saudi Arabia
7
Department of Child Health, College of Medicine, University of Bisha, Bisha 61922, Saudi Arabia
8
Department of Medical Education and Internal Medicine, College of Medicine, University of Bisha, Bisha 61922, Saudi Arabia
9
Department of Histology and Cell Biology, Faculty of Medicine, Assiut University, Assiut 71515, Egypt
10
Unit of Anatomy, Department of Basic Medical Sciences, College of Medicine, University of Bisha, Bisha 61922, Saudi Arabia
11
Department of Internal Medicine, Division of Dermatology, College of Medicine, University of Bisha, Bisha 61922, Saudi Arabia
12
Department of Internal Medicine, College of Medicine, University of Bisha, Bisha 61922, Saudi Arabia
13
Department of Basic Medical Sciences, College of Medicine, University of Bisha, Bisha 61922, Saudi Arabia
14
Department of Clinical Pathology, Faculty of Medicine, Suez Canal University, Ismailia 41522, Egypt
15
Department of Clinical Pharmacology, Faculty of Medicine, Mansoura University, Mansoura 35516, Egypt
16
Pharmacology and Therapeutics Department, Qassim College of Medicine, Qassim University, Buraydah 51452, Saudi Arabia
17
Physiology Department, Benha Faculty of Medicine, Benha University, Benha 13518, Egypt
18
Physiology Department, Albaha Faculty of Medicine, Albaha University, Al Baha 65799, Saudi Arabia
19
Department of Biochemistry, Faculty of Pharmacy, Badr University in Cairo, Cairo 11829, Egypt
20
Department of Biochemistry and Molecular Biology, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo 11231, Egypt
21
Biological Sciences Department, College of Science, King Faisal University, Al Ahsa 31982, Saudi Arabia
22
Central Laboratory, Theodor Bilharz Research Institute, Giza 12411, Egypt
23
Department of Pharmacology, Faculty of Pharmacy, Delta University for Science and Technology, Gamasa 11152, Egypt
 
add Show full affiliation list
 
remove Hide full affiliation list
*
Authors to whom correspondence should be addressed.
Pharmaceuticals 2025, 18(7), 1011; https://doi.org/10.3390/ph18071011
Submission received: 26 June 2025 / Accepted: 1 July 2025 / Published: 7 July 2025
Browse Figure
Versions Notes
In the original publication [1], there was a mistake in Figure 2, as published. An image from group E was mistakenly placed in group C in Figure 2 due to an incorrect folder selection. This error was facilitated by the fact that the image selected for group C exhibited normal structures with no observable tissue changes, making it visually indistinguishable from the intended selection. The correct Figure 2 and it’s legend appears below. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
The authors wish to replace the ‘Author Contributions’ statement for this article [1] with the following version since the wrong version was uploaded due to oversight:
  • Author Contributions: Conceptualization, S.S.; methodology, O.A.M., M.A.A.-R., L.A.S., M.M.S.A., J.A., M.I.E.A., A.A.F., A.A.J.A., W.F.B., A.A.H., S.A.-G., E.A.E., H.S.E.-w., A.S.D. and R.S.H.; software, S.S.; validation, O.A.M., M.A.A.-R. and S.S.; formal analysis, O.A.M. and S.S.; investigation, O.A.M., M.A.A.-R., L.A.S., M.M.S.A., J.A., M.I.E.A., A.A.F., A.A.J.A., W.F.B., A.A.H., S.A.-G., E.A.E., H.S.E.-w., A.S.D., R.S.H. and S.S.; resources, O.A.M., M.A.A.-R., L.A.S., M.M.S.A., J.A., M.I.E.A., A.A.F., A.A.J.A., W.F.B., A.A.H., S.A.-G., E.A.E., H.S.E.-w., A.S.D. and R.S.H.; software, S.S.; validation, O.A.M., M.A.A.-R. and S.S.; data curation, O.A.M., M.A.A.-R., L.A.S., A.A.F., A.A.J.A., A.A.H., E.A.E., H.S.E.-w. and A.S.D.; contributed to writing—original draft preparation, O.A.M., M.A.A.-R., L.A.S., M.M.S.A., J.A., M.I.E.A., A.A.F., A.A.J.A., W.F.B., A.A.H., S.A.-G., E.A.E., H.S.E.-w., A.S.D., R.S.H. and S.S.; writing—review and editing, O.A.M., M.A.A.-R., L.A.S., M.M.S.A., J.A., M.I.E.A., A.A.F., A.A.J.A., W.F.B., A.A.H., S.A.-G., E.A.E., H.S.E.-w., A.S.D., R.S.H. and S.S.; visualization, A.A.F., J.A., A.A.J.A., W.F.B. and A.A.H.; supervision, M.M.S.A., J.A., M.I.E.A., A.A.J.A., W.F.B., A.A.H., S.A.-G., A.S.D. and S.S.; project administration, O.A.M., A.S.D. and S.S.; funding acquisition, O.A.M. All authors have read and agreed to the published version of the manuscript.
The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. The original article has been updated. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Mohammed, O.A.; Abdel-Reheim, M.A.; Saleh, L.A.; Alamri, M.M.S.; Alfaifi, J.; Adam, M.I.E.; Farrag, A.A.; AlQahtani, A.A.J.; BinAfif, W.F.; Hashish, A.A.; et al. Alvespimycin Exhibits Potential Anti-TGF-β Signaling in the Setting of a Proteasome Activator in Rats with Bleomycin-Induced Pulmonary Fibrosis: A Promising Novel Approach. Pharmaceuticals 2023, 16, 1123. [Google Scholar] [CrossRef] [PubMed]
Pharmaceuticals 18 01011 g002
Figure 2. Effect of the alvespimycin, OLPN, and their combined therapy on the histological structure of the lung. Sections of CTRL (A), 17-DMAG (B), and OLPN (C), respectively, show normal lung architecture formed of thin-walled alveoli. Section of BLCN-treated rats (D) shows substantial inflammatory cellular infiltration (asterisk) and marked thickening of inter-alveolar septa (forked arrow) compared to CTRL, 17-DMAG, or OLPN rats. Lung sections from rats with pulmonary fibrosis treated with 17-DMAG (E), OLPN (F), and their combined therapy (G) reveal mild inflammatory cellular infiltration and alveolar septal thickening (forked arrows) as confirmed by the inflammation score (H). Significance is indicated by the pairwise comparisons. * p < 0.05 vs. BLCN; *** p < 0.001 vs. CTRL.
Figure 2. Effect of the alvespimycin, OLPN, and their combined therapy on the histological structure of the lung. Sections of CTRL (A), 17-DMAG (B), and OLPN (C), respectively, show normal lung architecture formed of thin-walled alveoli. Section of BLCN-treated rats (D) shows substantial inflammatory cellular infiltration (asterisk) and marked thickening of inter-alveolar septa (forked arrow) compared to CTRL, 17-DMAG, or OLPN rats. Lung sections from rats with pulmonary fibrosis treated with 17-DMAG (E), OLPN (F), and their combined therapy (G) reveal mild inflammatory cellular infiltration and alveolar septal thickening (forked arrows) as confirmed by the inflammation score (H). Significance is indicated by the pairwise comparisons. * p < 0.05 vs. BLCN; *** p < 0.001 vs. CTRL.
Pharmaceuticals 18 01011 g002
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Mohammed, O.A.; Abdel-Reheim, M.A.; Saleh, L.A.; Alamri, M.M.S.; Alfaifi, J.; Adam, M.I.E.; Farrag, A.A.; AlQahtani, A.A.J.; BinAfif, W.F.; Hashish, A.A.; et al. Correction: Mohammed et al. Alvespimycin Exhibits Potential Anti-TGF-β Signaling in the Setting of a Proteasome Activator in Rats with Bleomycin-Induced Pulmonary Fibrosis: A Promising Novel Approach. Pharmaceuticals 2023, 16, 1123. Pharmaceuticals 2025, 18, 1011. https://doi.org/10.3390/ph18071011

AMA Style

Mohammed OA, Abdel-Reheim MA, Saleh LA, Alamri MMS, Alfaifi J, Adam MIE, Farrag AA, AlQahtani AAJ, BinAfif WF, Hashish AA, et al. Correction: Mohammed et al. Alvespimycin Exhibits Potential Anti-TGF-β Signaling in the Setting of a Proteasome Activator in Rats with Bleomycin-Induced Pulmonary Fibrosis: A Promising Novel Approach. Pharmaceuticals 2023, 16, 1123. Pharmaceuticals. 2025; 18(7):1011. https://doi.org/10.3390/ph18071011

Chicago/Turabian Style

Mohammed, Osama A., Mustafa Ahmed Abdel-Reheim, Lobna A. Saleh, Mohannad Mohammad S. Alamri, Jaber Alfaifi, Masoud I. E. Adam, Alshaimaa A. Farrag, AbdulElah Al Jarallah AlQahtani, Waad Fuad BinAfif, Abdullah A. Hashish, and et al. 2025. "Correction: Mohammed et al. Alvespimycin Exhibits Potential Anti-TGF-β Signaling in the Setting of a Proteasome Activator in Rats with Bleomycin-Induced Pulmonary Fibrosis: A Promising Novel Approach. Pharmaceuticals 2023, 16, 1123" Pharmaceuticals 18, no. 7: 1011. https://doi.org/10.3390/ph18071011

APA Style

Mohammed, O. A., Abdel-Reheim, M. A., Saleh, L. A., Alamri, M. M. S., Alfaifi, J., Adam, M. I. E., Farrag, A. A., AlQahtani, A. A. J., BinAfif, W. F., Hashish, A. A., Abdel-Ghany, S., Elmorsy, E. A., El-wakeel, H. S., Doghish, A. S., Hamad, R. S., & Saber, S. (2025). Correction: Mohammed et al. Alvespimycin Exhibits Potential Anti-TGF-β Signaling in the Setting of a Proteasome Activator in Rats with Bleomycin-Induced Pulmonary Fibrosis: A Promising Novel Approach. Pharmaceuticals 2023, 16, 1123. Pharmaceuticals, 18(7), 1011. https://doi.org/10.3390/ph18071011

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop